Schiess Ralph 4
4 · Onconetix, Inc. · Filed Sep 26, 2024
Insider Transaction Report
Form 4
Onconetix, Inc.ONCO
Schiess Ralph
Interim CEO, CSO
Transactions
- Award
Common Stock
2024-09-24+489,160→ 495,903 total
Footnotes (1)
- [F1]Represents shares of common stock of the Issuer issued to the Reporting Person upon automatic conversion of Series B preferred stock ("Preferred Shares") of the Issuer, in accordance with the Certificate of Designation for the Preferred Shares.